[1]MOORE KP, AITHAL GP.Guidelines on the management of ascites in cirrhosis[J].Gut, 2006, 55 (Suppl 6) :1-12.
|
[2]RUNYON BA.Management of adult patients with ascites due to cirrhosis:An update[J].Hepatology, 2009, 49 (6) :2087-2107.
|
[3]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J].J Hepatol, 2010, 53 (3) :397-417.
|
[4]D'AMICO G, GARCIA-TSAO G, PAGLIARO L.Natural history and prognostic indicators of survival in cirrhosis:A systematic review of 118 studies[J].J Hepatol, 2006, 44 (1) :217-231.
|
[5]CHOLONGITAS E, PAPATHEODORIDIS GV, MANESIS EK, et al.Spontaneous bacterial peritonitis in cirrhotic patients:Is prophylactic propranolol therapy beneficial?[J].J Gastroenterol Hepatol, 2006, 21 (3) :581-587.
|
[6]JADAD AR, MOORE RA, CARROLL D, et al.Assessing the quality of reports of randomized clinical trials:Is blinding necessary?[J].Control Clin Trials, 1996, 17 (1) :1-12.
|
[7]HERNNDEZ PREZ RE, AGUILAR RAMREZ JR, HERNNDEZLPEZ JM, et al.Massive paracentesis and administration of dextran 70 vs albumin in cirrhotic patients with tense ascites[J].Rev Gastroenterol Mex, 1995, 60 (1) :22-26.
|
[8]BERTRN X, FERNNDEZ-BAARES F, PLANAS R, et al.Impact on the energetic-proteic nutritional status of total paracentesis combined with infusion of albumin or dextran-70 in the therapy of tension ascites in liver cirrhosis[J].Rev Esp Enferm Dig, 1991, 79 (5) :320-323.
|
[9]MOREAU R, VALLA DC, DURAND-ZALESKI I, et al.Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:A randomised controlled pilot trial[J].Liver International, 2006, 26 (1) :46-54.
|
[10]ALTMAN C, BERNARD B, ROULOT D, et al.Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis[J].Eur J Gastroenterol Hepatol, 1998, 10 (1) :5-10.
|
[11]GINS A, FERNNDEZ-ESPARRACH G, MONESCILLO A, et al.Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis[J].Gastroenterology, 1996, 111 (4) :1002-1010.
|
[12]SALERNO F, BADALAMENTI S, LORENZANO E, et al.Randomized comparative study of hemaccel vs.albumin infusion after total paracentesis in cirrhotic patients with refractory ascites[J].Hepatology, 1991, 13 (4) :707-713.
|
[13]GARCA-COMPEAN D, BLANC P, LARREY D, et al.Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis:A randomized controlled trial[J].Ann Hepatol, 2002, 1 (1) :29-35.
|
[14]FASSIO E, TERG R, LANDEIRA G, et al.Paracentesis with Dextran70 vs.aracentesis wit albumin in cirr with tense ascites results of a randomized study[J].J Hepatol, 1992, 14 (2-3) :310-316.
|
[15]PLANAS R, GINS P, ARROYO V, et al.Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis[J].Gastroenterology, 1990, 99 (6) :1736-1744.
|
[16]XU LL, SU L, WANG C, et al.Therapcutic effects of tolvaptan on patients of cirrhosis, ascites complicated with hyponatremia[J/CD].Chin J Liver Dis:Electr Version, 2018, 10 (2) :87-90. (in Chinese) 徐力力, 苏良, 王晨, 等.托伐普坦治疗伴低钠血症肝硬化腹水患者的疗效[J/CD].中国肝脏病杂志:电子版, 2018, 10 (2) :87-90.
|
[17]Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J].J Clin Hepatol, 2017, 33 (10) :1847-1863. (in Chinese) 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志, 2017, 33 (10) :1847-1863.
|
[18]RUIZ-DEL-ARBOL L, MONESCILLO A, JIMENEZ W, et al.Paracentesis-induced circulatory dysfunction:Mechanism and effect on hepatic hemodynamics in cirrhosis[J].Gastroenterology, 1997, 113 (2) :579-586.
|
[19]PREDESCU D, PREDESCU S, MALIK AB.Transport of nitrated albumin across continuous vascular endothelium[J].Proc Natl Acad Sci U S A, 2002, 99 (21) :13932-13937.
|
[20]SORT P, NAVASA M, ARROYO V, et al.Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis[J].N Engl JMed, 1999, 341 (6) :403-409.
|
[21]WU J, YIN F, LUO GH, et al.Association of hyponatremia with degree of liver injury and complications in patients with decompensated liver cirrhosis[J].J Clin Hepatol, 2017, 33 (2) :277-280. (in Chinese) 武健, 尹芳, 罗贯虹, 等.失代偿期肝硬化患者低钠血症与肝损伤程度及并发症的关系[J].临床肝胆病杂志, 2017, 33 (2) :277-280.
|
[22]WANG HQ, LIN Y, YAN Y.Clinical study on the significcance of hyponatremia in patients with cirrhotic ascites[J].J Clin Exp Med, 2017, 16 (22) :2275-2278. (in Chinese) 王慧卿, 林叶, 严艳.肝硬化腹水合并低钠血症的临床研究[J].临床和实验医学杂志, 2017, 16 (22) :2275-2278.
|